The US Food & Drug Administration (FDA) has approved Wegovy, along with diet and exercise, for two indications (specific uses), as follows: To reduce excess body weight and maintain weight reduction long term in people ages 12 and older with obesity and in people with overweight and have at least one weight-related condition, such as high blood pressure
Hyperglycaemia can also elevate levels of tumoir necrosis factor (TNF)- and interleukin (IL)-6, cytokines linked to increased osteoclast activity
"For far too long, this disease has remained unrecognized, undiagnosed, and often untreated, despite impacting so many people." - Dave Moore, executive vice president of US Operations at Novo Nordisk You can read more about the approval here
Every persons body is different
Muscle mass can be maintained, particularly when paired with resistance training
Switching is not just a matter of replacing one medication with another